China Resources Pharmaceutical Group Limited Share Price
Stocks
3320
HK0000311099
Pharmaceuticals
OTC Markets Traded|
Delayed
Hong Kong S.E.
09:08:27 30/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 4.450 HKD | +2.06% |
|
+1.95% | - |
| 09-01 | China Resources Pharma Unit's Bond Program Registration Accepted in China | MT |
| 08-24 | China Resources Pharmaceutical Group Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 27.96B 3.56B 3.14B 2.97B 2.68B 5.06B 342B 5.12B 35.57B 13.69B 175B 13.38B 13.09B 560B | P/E 2026 * |
5.71x | P/E 2027 * | 5.36x |
|---|---|---|---|---|---|
| Enterprise Value | 77.19B 9.84B 8.66B 8.21B 7.41B 13.97B 943B 14.15B 98.2B 37.79B 482B 36.94B 36.13B 1,546B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.21x |
| Free-Float |
29.17% | Yield 2026 * |
4.57% | Yield 2027 * | 4.95% |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 3320 | Delayed | |
Tradegate
| 640 | Real-time | |
|
Deutsche Boerse AG
| 640 | Delayed | |
|
Börse Stuttgart
| 640 | Delayed | |
|
Boerse Muenchen
| 640 | Real-time |
| 1 day | +2.06% | ||
| 1 week | +1.95% | ||
| 1 month | -0.45% | ||
| 3 months | +4.95% | ||
| 6 months | -23.01% |
| 1 week | 4.23 |  | 4.47 |
| 1 month | 4.23 | | 4.52 |
| Current year | 4.22 | | 6.53 |
| 1 year | 4.22 | | 6.53 |
| 3 years | 4.22 | | 7.11 |
| 5 years | 3.18 | | 8.13 |
| 10 years | 3.18 | | 13.16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Cheng
PSD | President | 47 | 25/08/2025 |
Rong Hui Deng
DFI | Director of Finance/CFO | 54 | 12/06/2023 |
Wing Yi Wan
SEC | Corporate Secretary | - | 14/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ting Mei Fu
BRD | Director/Board Member | 59 | 31/05/2016 |
Ke Jian Zhang
BRD | Director/Board Member | 70 | 19/06/2016 |
Xiao Song Bai
CHM | Chairman | 55 | 28/08/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/04/20 | Other | Chief Executive Officer | 200,000 | 0.0032% | ||
| 31/03/20 | Other | Chief Executive Officer | 100,000 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.06% | +1.95% | -7.48% | -14.42% | 3.49B | |
| -2.33% | +0.53% | +51.65% | +115.42% | 1,056B | |
| -1.06% | -1.65% | +42.78% | +69.98% | 645B | |
| -0.65% | -1.32% | +12.98% | +75.49% | 465B | |
| -2.66% | -1.87% | +73.13% | +41.15% | 368B | |
| -0.06% | -3.88% | +34.32% | +39.39% | 335B | |
| -0.79% | +2.01% | +19.82% | +27.79% | 275B | |
| -1.19% | -1.21% | +9.82% | +10.61% | 255B | |
| -0.50% | +3.80% | +49.37% | +56.84% | 229B | |
| -1.47% | -1.53% | +34.28% | +98.89% | 188B | |
| Average | -0.55% | -0.08% | +32.07% | +52.11% | 381.93B | |
| Weighted average by Cap. | -1.02% | -0.23% | +39.87% | +71.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 328B 41.77B 36.78B 34.85B 31.46B 59.3B 4,005B 60.07B 417B 160B 2,047B 157B 153B 6,564B | 340B 43.37B 38.19B 36.18B 32.66B 61.56B 4,158B 62.36B 433B 167B 2,126B 163B 159B 6,815B |
| Net income | 4.82B 614M 541M 512M 462M 872M 58.86B 883M 6.13B 2.36B 30.09B 2.31B 2.25B 96.48B | 5.17B 659M 580M 550M 496M 935M 63.18B 948M 6.58B 2.53B 32.3B 2.47B 2.42B 104B |
| Net Debt | 49.24B 6.27B 5.53B 5.24B 4.73B 8.91B 602B 9.02B 62.63B 24.1B 308B 23.56B 23.05B 986B | 42.53B 5.42B 4.77B 4.52B 4.08B 7.69B 520B 7.79B 54.1B 20.82B 266B 20.35B 19.91B 852B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/09/26 | HK$4.450 | +2.06% | 9,132,126 |
| 29/09/26 | HK$4.360 | +0.11% | 6,317,000 |
| 28/09/26 | HK$4.355 | +1.40% | 5,225,000 |
| 25/09/26 | HK$4.295 | -0.81% | 1,517,646 |
| 24/09/26 | HK$4.330 | -0.80% | 5,820,000 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 3320 Stock
Select your edition
All financial news and data tailored to specific country editions
